Transplant stories

Real Treatments. Real Families. Real Hope.

Smart Cells was the first private UK stem cell bank to release samples for transplant — proving that family cord blood banking is not just about storage, but about delivering real therapies when they are needed most.

Why Stem Cell Transplants Matter

At some point in life, your child or family member may need access to stem cell therapy. Today, these treatments are being used for:

Blood cancers such as leukaemia and lymphoma
Inherited genetic disorders including thalassemia and sickle cell disease
Neurological conditions such as cerebral palsy and brain injury
Immune deficiencies and metabolic disorders
Emerging therapies for sports injuries, inflammatory conditions, and skin repair

By preserving your baby’s umbilical cord blood and tissue, you safeguard access to these life-saving and life-enhancing possibilities.

Proven Track Record

Smart Cells has released more stem cell samples for treatment than any other private UK bank, with a 100% success rate for every sample delivered to clinicians worldwide.

These samples have helped children and families across the globe face illnesses such as:

Cerebral Palsy
Thalassemia
Leukaemia
HSV Encephalitis
Immune system disorders

Each transplant is more than a statistic — it represents a child given new options, and a family given hope.

A Milestone for Families and for Science

Every successful release shows how far the field of stem cell research has advanced. What was once only a possibility is now a proven therapy.

Yet many parents are still unaware of the benefits of storing their baby’s cord blood and tissue. Smart Cells is working to change that — by raising awareness, sharing real transplant stories, and supporting research into the next generation of regenerative treatments.

Powered by FamiCord: Europe’s Stem Cell Leader in banking and use of cells

As part of the FamiCord Group, Europe’s largest family stem cell bank and one of the world’s top three:

Families gain access to 1,000,000+ stored cord blood units across the network
Therapies are supported by specialist research centres and clinical teams in 35+ countries including FamiCord Programme for brain disorders
FamiCordTx, the group’s advanced therapies division, is actively developing new cell-based treatments to extend the possibilities for families everywhere

Together, Smart Cells and FamiCord stand at the forefront of innovation, offering parents confidence today — and hope for tomorrow.

Order now Find out more

FamiCord Group releases

Patients

7800+

Expand table
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
8001	Apheresis	Autologous	Small Cell Ovarian Carcinoma	Hematology	2016	Standard Therapy	Germany	18
8002	Apheresis	Allogeneic	T Cell Lymphoma/ Nos – Not Otherwise Specified	Hematology	2016	Standard Therapy	Poland	55
8003	Apheresis	Allogeneic	T-Cell Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	19
8004	Apheresis	Allogeneic	T-Cell Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	21
8005	Apheresis	Allogeneic	T-Cell Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	41
8006	Apheresis	Allogeneic	T-Cell Leukemia/Lymphoma	Hematology	2016	Standard Therapy	Poland	31
8007	Apheresis	Autologous	T-Cell Non-Hodgkin Lymphoma	Hematology	2016	Standard Therapy	Germany	48
8008	Apheresis	Allogeneic	T-Cell Non-Hodgkin Lymphoma	Hematology	2016	Standard Therapy	Germany	24
8009	Apheresis	Autologous	T-Cell-Lymphoma	Hematology	2016	Standard Therapy	Germany	55
8010	Apheresis	Autologous	T-Cell-Lymphoma	Hematology	2016	Standard Therapy	Germany	33
8011	Apheresis	Allogeneic	T-Cell-Prolymphocytic Leukemia	Hematology	2016	Standard Therapy	Poland	61
8012	Apheresis	Allogeneic	Wiskott-Aldrich Syndrome	Hematology	2016	Standard Therapy	Poland	1
8013	Apheresis	Allogeneic	X-Linked Lymphoproliferative Disease	Hematology	2016	Standard Therapy	Poland	12
8014	Cord Tissue	Allogeneic – Unrelated	Acute Graft Versus Host Disease	Hematology	2015	Experimental Therapy	Poland	1,4
8015	Cord Tissue	Allogeneic – Unrelated	Acute Graft Versus Host Disease	Hematology	2015	Experimental Therapy	Poland	11 months
8016	Cord Tissue	Allogeneic – Unrelated	Acute Graft Versus Host Disease	Hematology	2015	Experimental Therapy	Poland	51,5
8017	Cord Tissue	Allogeneic – Unrelated	Acute Graft Versus Host Disease	Hematology	2015	Experimental Therapy	Poland	6,6
8018	Cord Tissue	Allogeneic – Unrelated	Acute Graft Versus Host Disease	Hematology	2015	Experimental Therapy	Poland	13,4
8019	Cord Tissue	Allogeneic – Unrelated	Adrenoleukodystrophy; Encephalopathy	Neurology	2015	Experimental Therapy	Poland	23
8020	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	61,6
8021	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	61
8022	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	56
8023	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	51
8024	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	65
8025	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	60
8026	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	52
8027	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	59,4
8028	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	61,5
8029	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	58
8030	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	61,6
8031	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	62
8032	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	26,5
8033	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	27
8034	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	63,11
8035	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	67,6
8036	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	37,6
8037	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	58,1
8038	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	46,2
8039	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	48,7
8040	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	61,3
8041	Cord Tissue	Allogeneic – Unrelated	Amyotrophic Lateral Sclerosis	Neurology	2015	Experimental Therapy	Poland	54
8042	Cord Tissue	Allogeneic – Unrelated	Anterior Ischemic Optic Neuropathy	Ophthalmology	2015	Experimental Therapy	Poland	54,1
8043	Cord Tissue	Allogeneic – Unrelated	Autism	Neurology	2015	Experimental Therapy	Poland	5,4
8044	Cord Tissue	Allogeneic – Unrelated	Autism	Neurology	2015	Experimental Therapy	Poland	3
8045	Cord Tissue	Allogeneic – Unrelated	Autism	Neurology	2015	Experimental Therapy	Poland	12,5
8046	Cord Tissue	Allogeneic – Unrelated	Autism	Neurology	2015	Experimental Therapy	Poland	6,1
8047	Cord Tissue	Allogeneic – Unrelated	Autism	Neurology	2015	Experimental Therapy	Poland	4,6
8048	Cord Tissue	Allogeneic – Unrelated	Autism	Neurology	2015	Experimental Therapy	Poland	5,6
8049	Cord Tissue	Allogeneic – Unrelated	Autism	Neurology	2015	Experimental Therapy	Poland	8,7
8050	Cord Tissue	Allogeneic – Unrelated	Bilateral Blindness	Ophthalmology	2015	Experimental Therapy	Poland	36,1
8051	Cord Tissue	Allogeneic – Unrelated	Cerebellar Ataxia	Neurology	2015	Experimental Therapy	Poland	18,7
8052	Cord Tissue	Allogeneic – Unrelated	Cerebellar Ataxia	Neurology	2015	Experimental Therapy	Poland	26,1
8053	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	3,8
8054	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	15,8
8055	Cord Tissue	Allogeneic – Unrelated & Related	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	7,1
8056	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	13,1
8057	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	8,11
8058	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	2,7
8059	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	12,1
8060	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	4,1
8061	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	22
8062	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	9,9
8063	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	1,6
8064	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	14,1
8065	Cord Tissue	Allogeneic – Unrelated	Cerebral Palsy	Neurology	2015	Experimental Therapy	Poland	16,9
8066	Cord Tissue	Allogeneic – Unrelated	Ceroid Lipofuscinosis	Neurology	2015	Experimental Therapy	Poland	5,1
8067	Cord Tissue	Allogeneic – Unrelated	Ceroid Lipofuscinosis	Neurology	2015	Experimental Therapy	Poland	7,1
8068	Cord Tissue	Allogeneic – Unrelated	Chronic Graft Versus Host Disease	Hematology	2015	Experimental Therapy	Poland	10
8069	Cord Tissue	Allogeneic – Unrelated	Decerebration Rigidity	Neurology	2015	Experimental Therapy	Poland	9,6
8070	Cord Tissue	Allogeneic – Unrelated	Delayed Psychomotor Development	Neurology	2015	Experimental Therapy	Poland	3,6
8071	Cord Tissue	Allogeneic – Unrelated	Delayed Psychomotor Development, Deafness	Neurology	2015	Experimental Therapy	Poland	3,3
8072	Cord Tissue	Allogeneic – Unrelated	Encephalopathy	Neurology	2015	Experimental Therapy	Poland	14,5
8073	Cord Tissue	Allogeneic – Unrelated	Encephalopathy	Neurology	2015	Experimental Therapy	Poland	8 months
8074	Cord Tissue	Allogeneic – Unrelated & Related	Encephalopathy	Neurology	2015	Experimental Therapy	Poland	11,2
8075	Cord Tissue	Allogeneic – Unrelated	Facioscapulohumeral Muscular Dystrophy	Neurology	2015	Experimental Therapy	Poland	30,1
8076	Cord Tissue	Allogeneic – Unrelated	Gonarthrosis	Orthopedy	2015	Experimental Therapy	Poland	66
8077	Cord Tissue	Allogeneic – Unrelated	Gonarthrosis	Orthopedy	2015	Experimental Therapy	Poland	65
8078	Cord Tissue	Allogeneic – Unrelated	Iatrogenic Spinal Cord Injury	Neurology	2015	Experimental Therapy	Poland	17,2
8079	Cord Tissue	Allogeneic – Unrelated	Intracranial Injury	Neurology	2015	Experimental Therapy	Poland	24,3
8080	Cord Tissue	Allogeneic – Unrelated	Leukodystrophy	Neurology	2015	Experimental Therapy	Poland	18,8
8081	Cord Tissue	Allogeneic – Unrelated	Optic Neuropathy	Ophthalmology	2015	Experimental Therapy	Poland	15,8
8082	Cord Tissue	Allogeneic – Unrelated	Optic Neuropathy	Ophthalmology	2015	Experimental Therapy	Poland	45,1
8083	Cord Tissue	Allogeneic – Unrelated	Polyneuropathy	Neurology	2015	Experimental Therapy	Poland	74,2
8084	Cord Tissue	Allogeneic – Unrelated	Retinitis Pigmentosa	Ophthalmology	2015	Experimental Therapy	Poland	34,5
8085	Cord Tissue	Allogeneic – Unrelated	Sclerosis Multiplex	Neurology	2015	Experimental Therapy	Poland	23,2
8086	Cord Tissue	Allogeneic – Unrelated	Sclerosis Multiplex	Neurology	2015	Experimental Therapy	Poland	33,3
8087	Cord Tissue	Allogeneic – Unrelated	Severe Developmental Delay	Neurology	2015	Experimental Therapy	Poland	1,1
8088	Cord Tissue	Allogeneic – Unrelated	Spina Bifida	Neurology	2015	Experimental Therapy	Poland	2
8089	Cord Tissue	Allogeneic – Unrelated	Spinal Cord Injury	Orthopedy	2015	Experimental Therapy	Poland	31,2
8090	Cord Tissue	Allogeneic – Unrelated	Spinal Cord Injury	Orthopedy	2015	Experimental Therapy	Poland	18,8
8091	Cord Tissue	Allogeneic – Unrelated	Spinal Cord Injury	Orthopedy	2015	Experimental Therapy	Poland	40
8092	Cord Tissue	Allogeneic – Unrelated	Spinal Cord Injury	Orthopedy	2015	Experimental Therapy	Poland	26,1
8093	Cord Tissue	Allogeneic – Unrelated	Spinal Cord Injury	Orthopedy	2015	Experimental Therapy	Poland	37,1
8094	Cord Tissue	Allogeneic – Unrelated	Spinal Cord Injury	Orthopedy	2015	Experimental Therapy	Poland	32,1
8095	Cord Tissue	Allogeneic – Unrelated	Spinal Cord Injury	Orthopedy	2015	Experimental Therapy	Poland	21,4
8096	Cord Tissue	Allogeneic – Unrelated	Spinal Cord Injury	Orthopedy	2015	Experimental Therapy	Poland	24,7
8097	Cord Tissue	Allogeneic – Unrelated	Spinal Cord Injury	Orthopedy	2015	Experimental Therapy	Poland	34,4
8098	Cord Tissue	Allogeneic – Unrelated	Spinal Muscular Atrophy	Neurology	2015	Experimental Therapy	Poland	11 months
8099	Cord Tissue	Allogeneic – Unrelated	Spinal Muscular Atrophy	Neurology	2015	Experimental Therapy	Poland	26,2
8100	Cord Tissue	Allogeneic – Unrelated	Spinocerebellar Ataxia	Neurology	2015	Experimental Therapy	Poland	35,6

Page 81 of 89 1 79 80 81 82 83 89

Expand table

Stem cell transplantation has become an established procedure

700,000

cord blood collections have been undertaken globally

50,000

hematopoietic stem cell transplants take place every year

400/500

of these transplants are in Europe

Our transplant stories

Smart Cells have released 24 UK
samples to six countries.

Stem cells hold the key to more than 80 life-changing treatments, with clinical trials underway on many more. Replacing damaged cells and tissue, they can even save a child’s life.

100% infusion success rate

For samples released for transplant.

3 months – 12 yrs old

Stored cord blood samples have been successfully released for use in transplant for children aged as little as 3 months to 12 years old.

46% self | 54% siblings

Smart Cells have successfully released stored cord blood samples that have been used for treatment with the child it was collected from and also siblings.

Smart Cells releases

UK samples released

Expand table
Sample release date	Medical condition	Recipient relationship	Age of the recipient	Unit volume	Medical center	Country
2005.11	Thalassemia	Allogeneic (Sibling)	4 Years	144ml	Mount Vernon Hospital	Singapore
2005.11	Leukaemia	Allogeneic (Sibling)	Restricted	Restricted	Stem Cells and Immunology Department, Birmingham	UK
2007.02	Thalassemia	Allogeneic (Sibling)	7 Years	76ml	Kinderlink der Tu Munchen	Germany
2009.08	Cerebral Palsy	Autologous (Self)	3 Years	51ml	Duke University, North Carolina	USA
2010.01	Cerebral Palsy	Autologous (Self)	3 Years	81ml	Duke University, North Carolina	USA
2013.10	Thalassemia	Allogeneic (Sibling)	5 Years	58ml	Catherine Lewis Centre, Hammersmith	UK
2014.01	Leukaemia	Allogeneic (Sibling)	4 Years	71ml	Medizinische Hochschule, Hanover	Germany
2014.05	Cerebral Palsy	Autologous (Self)	1 year	68ml	Duke University, North Carolina	USA
2014.06	HSV Encephalitis & NMDA Receptor Antibody Virus	Autologous (Self)	2 Years	57ml	Duke University, North Carolina	USA
2014.08	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	3 Months	39ml	Duke University, North Carolina	USA
2015.02	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	6 Months	53ml	Duke University, North Carolina	USA
2015.03	Severe Combined Immune Deficiency	Autologous (Self)	3 Months	74ml	Duke University, North Carolina	USA
2015.03	Sickle Cell Disease	Allogeneic (Sibling)	2 .5 Years	57ml	BLK Hospital, New Delhi	India
2015.11	Thalassemia	Allogeneic (Sibling)	12 Years	87ml	Children’s Hospital of Pittsburgh of UPMC	USA
2016.03	Cerebral Palsy	Allogeneic (Sibling)	6 Years	101ml	Duke University, North Carolina	USA
2017.04	Lymphoblastic Leukaemia (^1)	N/A (Identical twin girls)	Restricted	125ml	Bambin Gesu Childrens’ Hospital, Rome	Italy
2017.06	Cerebral Palsy	Autologous (Self)	7 Years	82ml	Duke University, North Carolina	USA
2017.06	Cerebral Palsy	Autologous (Self)	3.4 Years	132ml	Duke University, North Carolina	USA
2018.03	Autism	Autologous (Self)	5.4 Years	73ml	Duke University, North Carolina	USA
2018.03	Cerebral Palsy	Autologous (Self)	3.4 years	132ml	Duke University, North Carolina	USA
2019.06	Cerebral Palsy	Allogeneic (Sibling)	3 Years	104ml	Duke University, North Carolina	USA
2022.02	Cerebral Palsy	Allogeneic (Sibling)	11 Years	185ml	Duke University, North Carolina	USA
2023.08	Cerebral Palsy	Allogeneic (Sibling)	3 Years	46ml	Duke University, North Carolina	USA
2024.01	Thalassaemia	Allogeneic (Sibling)	8 Years	45ml	Cincinnati Children’s Hospital Medical Center	USA